Past two years | Past Year | Past 30 Days | |
---|---|---|---|
Abstract Views | 235 | 106 | 33 |
Full Text Views | 12 | 0 | 0 |
PDF Downloads | 3 | 0 | 0 |
The reactions noted in a series of 286 patients treated with Ciba-1906 for various dermatologic conditions were mild and subsided after the drug was discontinued. In one patient the eruption recurred promptly following a test dose. Nausea, diarrhea and a bad taste in the mouth were other reactions noted. Drug allergy should be considered when morbilliform eruptions appear in patients under Ciba-1906 therapy.